Answer
Elrexfio (elranatamab) is administered only by subcutaneous injection by a healthcare professional, preferably into the abdomen or alternatively the thigh, avoiding skin that is red, bruised, tender, hard or scarred.
Sources for this answer
- ELREXFIO 40 mg/mL solution for injectionPfizer Limited · emc · SmPC §4.2 Posology and method of administration · Version 8Document updated
Sources checked